Momcilovic, Milica
Jones, Anthony
Bailey, Sean T.
Waldmann, Christopher M.
Li, Rui
Lee, Jason T.
Abdelhady, Gihad
Gomez, Adrian
Holloway, Travis
Schmid, Ernst
Stout, David
Fishbein, Michael C.
Stiles, Linsey
Dabir, Deepa V.
Dubinett, Steven M.
Christofk, Heather
Shirihai, Orian
Koehler, Carla M.
Sadeghi, Saman
Shackelford, David B.
Article History
Received: 21 December 2017
Accepted: 26 September 2019
First Online: 30 October 2019
Change Date: 3 January 2020
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: S.M.D. is an advisory board member for EarlyDx Inc., T-Cure Bioscience Inc., Cynvenio Biosystems Inc. and the Johnson and Johnson Lung Cancer Initiative. D.B.S., M.M. and S.S. have filed a provisional patent US 62/901,947 and are listed as inventors for the use of <sup>18</sup>F-BnTP to guide use of complex I inhibitors for the treatment of lung cancer.